Asia Pacific Sleep Aids market will grow by 8.5% annually with a total addressable market cap of $325,998.9 billion over 2022-2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices.
Highlighted with 29 tables and 51 figures, this 117-page report 鈥淎sia Pacific Sleep Aids 麻豆原创 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Smart Bedding
鈥� Sleep Lab Services
鈥� Sleep Apnea Devices
o Adaptive Servo-Ventilators (ASVs)
o Positive Airway Pressure (PAP) Devices
o Oral Appliances
o Facial Interfaces
o Other Sleep Apnea Devices
鈥� Medication
o Prescription Drugs
o OTC Drugs
o Herbal Drugs
鈥� Wearable Devices
鈥� Other Product Types
Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Insomnia
鈥� Sleep Apnea
鈥� Narcolepsy
鈥� Restless Leg Syndrome
鈥� REM Sleep Behavior Disorder
鈥� Sleepwalking
鈥� Other Indications
By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Drug Stores
鈥� E-Commerce
鈥� Hospital Pharmacies
鈥� Retail Pharmacies
Geographically, the following national/local markets are fully investigated:
鈥� Japan
鈥� China
鈥� South Korea
鈥� Australia
鈥� India
鈥� Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Advanced Brain Monitoring Inc.
Apex Medical Corp.
Apnea Sciences Corporation
BMC Medical Co., Ltd.
Braebon Medical Corp.
Cadwell Industries Inc.
Cleveland Medical Devices Inc.
Compumedics Limited
Drive DeVilbiss Healthcare Inc.
Fisher & Paykel Healthcare Corp. Ltd.
GlaxoSmithKline plc
Itamer Medical Ltd.
Koninklijke Philips N. V.
Merck & Co., Inc.
Natus Medical Inc.
Nihon Kohden Corporation
Pfizer Inc.
ResMed Inc.
Sanofi S. A.
Sleep Number Corporation
SleepMed Inc.
SomnoMed Inc.
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 29
2.4 Emerging Opportunities and 麻豆原创 Trends 32
2.5 Porter鈥檚 Fiver Forces Analysis 36
3 Segmentation of Asia Pacific 麻豆原创 by Product Type 40
3.1 麻豆原创 Overview by Product Type 40
3.2 Smart Bedding 42
3.3 Sleep Lab Services 43
3.4 Sleep Apnea Devices 44
3.4.1 Adaptive Servo-Ventilators (ASVs) 46
3.4.2 Positive Airway Pressure (PAP) Devices 47
3.4.3 Oral Appliances 48
3.4.4 Facial Interfaces 49
3.4.5 Other Sleep Apnea Devices 50
3.5 Medication 51
3.5.1 Prescription Drugs 52
3.5.2 OTC Drugs 53
3.5.3 Herbal Drugs 54
3.6 Wearable Devices 55
3.7 Other Product Types 56
4 Segmentation of Asia Pacific 麻豆原创 by Indication 57
4.1 麻豆原创 Overview by Indication 57
4.2 Insomnia 59
4.3 Sleep Apnea 60
4.4 Narcolepsy 61
4.5 Restless Leg Syndrome 62
4.6 REM Sleep Behavior Disorder 63
4.7 Sleepwalking 64
4.8 Other Indications 65
5 Segmentation of Asia Pacific 麻豆原创 by Distribution Channel 66
5.1 麻豆原创 Overview by Distribution Channel 66
5.2 Drug Stores 68
5.3 E-Commerce 69
5.4 Hospital Pharmacies 70
5.5 Retail Pharmacies 71
6 Asia-Pacific 麻豆原创 2021-2031 by Country 72
6.1 Overview of Asia-Pacific 麻豆原创 72
6.2 Japan 75
6.3 China 78
6.4 Australia 81
6.5 India 83
6.6 South Korea 85
6.7 Rest of APAC Region 87
7 Competitive Landscape 89
7.1 Overview of Key Vendors 89
7.2 New Product Launch, Partnership, Investment, and M&A 92
7.3 Company Profiles 93
Advanced Brain Monitoring Inc. 93
Apex Medical Corp. 95
Apnea Sciences Corporation 96
BMC Medical Co., Ltd. 97
Braebon Medical Corp. 98
Cadwell Industries Inc. 99
Cleveland Medical Devices Inc. 100
Compumedics Limited 101
Drive DeVilbiss Healthcare Inc. 102
Fisher & Paykel Healthcare Corp. Ltd. 103
GlaxoSmithKline plc 104
Itamer Medical Ltd. 105
Koninklijke Philips N. V. 106
Merck & Co., Inc. 107
Natus Medical Inc. 108
Nihon Kohden Corporation 109
Pfizer Inc. 110
ResMed Inc. 111
Sanofi S. A. 112
Sleep Number Corporation 113
SleepMed Inc. 114
SomnoMed Inc. 115
Teva Pharmaceutical Industries Ltd. 116
RELATED REPORTS 117
Selected Key Players:
Advanced Brain Monitoring Inc.
Apex Medical Corp.
Apnea Sciences Corporation
BMC Medical Co., Ltd.
Braebon Medical Corp.
Cadwell Industries Inc.
Cleveland Medical Devices Inc.
Compumedics Limited
Drive DeVilbiss Healthcare Inc.
Fisher & Paykel Healthcare Corp. Ltd.
GlaxoSmithKline plc
Itamer Medical Ltd.
Koninklijke Philips N. V.
Merck & Co., Inc.
Natus Medical Inc.
Nihon Kohden Corporation
Pfizer Inc.
ResMed Inc.
Sanofi S. A.
Sleep Number Corporation
SleepMed Inc.
SomnoMed Inc.
Teva Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
听
听
*If Applicable.